Bm Copper Arsenite (cuprum Ars)

For the prevention of pregnancy, the dosage of Cupric Arsenite is standardized by the device itself. A single device is inserted into the uterine cavity by a trained healthcare professional.

• Standard Contraceptive Dose: One intrauterine device containing approximately 380mm² of exposed copper surface area (or the equivalent in Cupric Arsenite formulation).
• Duration of Action: The device remains effective for up to 10 years of continuous use. It must be replaced or removed by the end of the 10th year.
• Emergency Contraception: A single device inserted within 120 hours of unprotected sexual intercourse.

Cupric Arsenite is approved for use in females of reproductive age, including post-menarcheal adolescents (those who have started their periods). There is no specific age-based dosage adjustment required, though the size of the uterus must be clinically evaluated to ensure the device can be properly accommodated. It is NOT indicated for use in children who have not yet reached menarche.

Renal Impairment

No dosage adjustments are necessary for patients with renal impairment, as systemic absorption of the active ions is minimal and does not rely on renal clearance for its primary contraceptive effect.

Hepatic Impairment

In general, no adjustment is needed for mild to moderate hepatic impairment. However, patients with Wilson’s Disease (a rare genetic disorder causing copper accumulation in the liver and brain) must not use Cupric Arsenite devices.

Elderly Patients

Cupric Arsenite is not indicated for postmenopausal women. If a patient reaches menopause while the device is in place, it should be removed, as it no longer serves a contraceptive purpose and may pose a risk for infection or difficult removal.

Cupric Arsenite is not 'taken' like a pill; it is 'placed' during a clinical procedure.

1. 1Timing: Insertion can occur at any time during the menstrual cycle, provided pregnancy is excluded. Insertion during or shortly after menstruation may be more comfortable as the cervix is naturally slightly more open.
2. 2Procedure: The healthcare provider uses a speculum to visualize the cervix, cleanses the area with an antiseptic, and uses an inserter tube to place the device through the cervical canal into the uterus.
3. 3Post-Insertion: Patients may experience cramping or spotting for several days. It is recommended to check the device strings once a month after the menstrual period to ensure the device remains in place.
4. 4Storage: The device is stored in its sterile packaging at room temperature (15°C to 30°C or 59°F to 86°F) until the moment of insertion.

Because the device provides continuous protection, there is no 'missed dose' in the traditional sense. However, if the device is expelled (partially or completely falls out), contraceptive protection is lost immediately. If you cannot feel the strings or if you feel the hard plastic of the device, contact your healthcare provider immediately and use a backup contraceptive method (like condoms).

Systemic overdose is virtually impossible with an intrauterine device. However, 'overdose' in this context may refer to the rare occurrence of having more than one device in the uterus or the accidental ingestion of the device components. Signs of acute copper or arsenic toxicity (if ingested) include severe nausea, vomiting, abdominal pain, and metallic taste. In the event of device breakage or migration, surgical intervention may be required.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to remove or adjust the device yourself, as this can cause injury or infection.

The most frequently reported side effects of Cupric Arsenite involve changes in menstrual patterns. These typically occur during the first 3 to 6 months after insertion and may improve over time.

• Increased Menstrual Bleeding (Menorrhagia): Periods may become significantly heavier or last longer than usual. This is due to the local inflammatory response in the uterine lining.
• Intermenstrual Spotting: Bleeding or spotting between periods is common as the uterus adjusts to the device.
• Dysmenorrhea (Menstrual Cramps): Patients often report more intense cramping during their periods. This can usually be managed with over-the-counter pain relievers like ibuprofen.
• Pelvic Pain: General discomfort or a 'heavy' feeling in the pelvic region may occur shortly after insertion.

• Expulsion: The uterus may occasionally push the device out through the cervix. This is more common in the first few months and in women who have never been pregnant.
• Vaginal Discharge: An increase in non-infectious vaginal discharge may occur.
• Pain During Intercourse (Dyspareunia): This may occur if the device has shifted or if the strings are irritating the partner or the patient.
• Anemia: Due to increased menstrual blood loss, some patients may develop iron-deficiency anemia over long-term use.

• Uterine Perforation: During insertion, the device may accidentally be pushed through the wall of the uterus. This requires surgical removal.
• Pelvic Inflammatory Disease (PID): While the device itself does not cause PID, the insertion process can introduce bacteria into the uterus. The risk is highest in the first 20 days post-insertion.
• Ectopic Pregnancy: If a pregnancy does occur while the device is in place, there is a higher statistical likelihood that it will be located outside the uterus (e.g., in the fallopian tubes).
• Arsenic Sensitivity: In extremely rare cases, individuals with hypersensitivity to arsenic compounds may experience localized tissue irritation or systemic allergic reactions.

> Warning: Stop using Cupric Arsenite (contact your doctor for removal) and seek immediate medical care if you experience any of the following:

• Severe Pelvic Pain or Tenderness: This may indicate PID, perforation, or an ectopic pregnancy.
• Unusually Heavy Bleeding: If you are soaking through a pad or tampon every hour, this is a medical emergency.
• Fever and Chills: Unexplained fever accompanied by pelvic pain or unusual vaginal discharge may indicate a serious infection.
• Missed Period: If you suspect you are pregnant, a pregnancy test is mandatory, as pregnancy with an IUD in place carries high risks for the mother and the fetus.
• Missing Strings: If you can no longer feel the strings, the device may have moved or been expelled.

With prolonged use (years), the primary long-term concern is the cumulative effect on iron stores due to heavier menstruation. Regular monitoring of hemoglobin and ferritin levels may be recommended by your healthcare provider. There is no evidence that long-term use of copper-based devices like Cupric Arsenite increases the risk of uterine or cervical cancer; in fact, some studies suggest a protective effect against endometrial cancer.

There are currently no FDA black box warnings specifically for Cupric Arsenite; however, all copper-containing IUDs carry strong warnings regarding the risk of Pelvic Inflammatory Disease (PID) and the necessity of screening for STIs prior to insertion to prevent life-threatening sepsis.

Report any unusual symptoms to your healthcare provider. Your provider can help determine if the side effects are manageable or if the device should be removed.

Cupric Arsenite is a highly effective contraceptive, but it is not suitable for everyone. It does not protect against HIV/AIDS or other sexually transmitted infections (STIs). Patients should use condoms if they are at risk for STIs. It is critical to ensure that the patient is not pregnant before the device is inserted, as insertion during pregnancy can lead to miscarriage, sepsis, or premature labor.

No FDA black box warnings for Cupric Arsenite are currently mandated. However, clinical guidelines emphasize the risk of sepsis if a patient becomes pregnant with the device in place. If pregnancy occurs, the device must be removed immediately if the strings are visible, or the pregnancy must be managed as high-risk.

• Allergic Reactions / Anaphylaxis Risk: Patients with a known allergy to copper, arsenic, or the plastic components of the device must avoid use. Signs of an allergic reaction include rash, itching, or swelling of the face and throat.
• Wilson’s Disease: This is a contraindication. The additional copper released by the device, though small, could theoretically exacerbate the condition.
• Uterine Abnormalities: Conditions that distort the uterine cavity (such as large fibroids) may prevent proper placement and increase the risk of expulsion or perforation.
• Ectopic Pregnancy: While the overall risk of pregnancy is very low, any pregnancy that occurs is more likely to be ectopic. This is a life-threatening condition requiring emergency surgery.

• Post-Insertion Check: A follow-up visit is typically scheduled 4 to 6 weeks after insertion to ensure the device is still properly positioned.
• String Checks: Patients are instructed to check for the strings once a month. If the strings feel longer, shorter, or are missing, a clinical evaluation is necessary.
• Hematologic Monitoring: If periods become excessively heavy, your doctor may order a Complete Blood Count (CBC) to check for anemia.

Cupric Arsenite does not affect the central nervous system. There are no restrictions on driving or operating machinery while using this device. However, immediately following the insertion procedure, some patients may feel lightheaded or dizzy (vasovagal reaction); it is advised to wait until these feelings pass before driving.

There are no known interactions between alcohol and Cupric Arsenite. However, excessive alcohol consumption can impair a patient's ability to monitor for side effects or attend follow-up appointments.

Cupric Arsenite can be removed at any time by a healthcare provider. Fertility returns to the patient's baseline immediately upon removal. There is no 'tapering' required, but if the patient does not wish to become pregnant, they should start another contraceptive method immediately or abstain from intercourse for 7 days prior to removal to ensure no viable sperm are present.

> Important: Discuss all your medical conditions with your healthcare provider before starting Cupric Arsenite, especially any history of pelvic infections or bleeding disorders.

There are no absolute drug-drug contraindications that would render Cupric Arsenite completely ineffective or dangerous. However, the device should not be used in conjunction with other intrauterine devices or systems.

• Anticoagulants and Antiplatelets (e.g., Warfarin, Clopidogrel, Apixaban): These medications may significantly worsen the increased menstrual bleeding associated with Cupric Arsenite. Patients on long-term anticoagulation therapy may require closer monitoring for anemia.
• Systemic Corticosteroids or Immunosuppressants: Long-term use of these drugs may theoretically increase the risk of pelvic infection by dampening the body's immune response. While not a contraindication, patients should be vigilant for signs of infection.

• Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (e.g., Ibuprofen, Naproxen): While NSAIDs are actually used to treat the cramping and heavy bleeding caused by the device, chronic high-dose use should be discussed with a doctor to ensure they are not masking signs of a more serious issue like PID.
• Radiotherapy: If a patient requires radiation therapy to the pelvic area, the presence of a metal-containing device should be disclosed to the radiologist, as metals can affect radiation dose distribution.

There are no known food interactions with Cupric Arsenite. Dietary intake of copper or arsenic through normal food sources does not affect the efficacy or safety of the intrauterine device.

• Zinc Supplements: High doses of oral zinc can interfere with copper absorption in the gut. While this does not affect the local release of copper from the IUD, patients with copper-related health issues should be aware of this balance.
• Garlic, Ginkgo, and Ginseng: These supplements have mild antiplatelet effects and could theoretically contribute to heavier menstrual flow.

• MRI (Magnetic Resonance Imaging): Most copper-containing devices are considered 'MRI Conditional.' This means they are safe for MRI under specific conditions. Always inform the MRI technician that you have an IUD.
• Serum Copper/Arsenic Levels: The device may cause a negligible increase in serum copper levels, which is usually not clinically significant but may be noted on sensitive toxicology screens.

For each major interaction, the mechanism is usually pharmacodynamic (affecting the body's response, such as bleeding) rather than pharmacokinetic (affecting drug levels). The management strategy typically involves monitoring symptoms and performing blood tests for iron levels if bleeding increases.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those used for menstrual symptom relief.

Cupric Arsenite must NEVER be used in the following circumstances:

1. 1Pregnancy: Insertion can cause severe infection, miscarriage, or maternal death.
2. 2Acute Pelvic Inflammatory Disease (PID): Or a history of PID unless there has been a subsequent normal pregnancy.
3. 3Current STI: Including acute cervicitis or vaginitis until the infection is fully resolved.
4. 4Uterine Malignancy: Known or suspected cancer of the uterus or cervix.
5. 5Unexplained Vaginal Bleeding: Bleeding that has not been evaluated by a doctor may be a sign of underlying pathology that the IUD could exacerbate.
6. 6Wilson’s Disease: A genetic disorder of copper metabolism.
7. 7Allergy to Components: Known hypersensitivity to copper, arsenic, or polyethylene.

These conditions require a careful risk-benefit analysis by a healthcare provider:

• Multiple Sexual Partners: Increases the risk of contracting an STI, which can lead to PID in IUD users.
• Recent Endometritis: Postpartum or post-abortion uterine infection within the last three months.
• Small Uterine Cavity: A uterus that measures less than 6 cm may be more prone to perforation or expulsion.
• Bleeding Disorders: Conditions like von Willebrand disease may make the increased menstrual flow unmanageable.

Patients who have had allergic reactions to other copper-containing medical devices (such as certain dental alloys or older IUD models) may be at higher risk for a reaction to Cupric Arsenite. There is no known cross-sensitivity with common antibiotics or hormonal contraceptives.

> Important: Your healthcare provider will evaluate your complete medical history, including a pelvic exam and potentially an ultrasound, before prescribing and inserting Cupric Arsenite.

Cupric Arsenite is strictly contraindicated during pregnancy. It is a Category X-equivalent (though the old FDA categories are being phased out). If a patient becomes pregnant with the device in place, there is a high risk of spontaneous abortion, septic abortion (a life-threatening infection of the uterus), and preterm labor. If the strings are visible, the device should be removed immediately by a professional. Removal carries a small risk of miscarriage but is generally safer than leaving the device in place.

Cupric Arsenite is considered safe for use during breastfeeding. Copper is a natural component of breast milk, and the tiny amount released by the device does not significantly alter the copper concentration in milk or affect the nursing infant. There is a slightly increased risk of uterine perforation if the device is inserted while a patient is lactating, likely due to the hormonal environment making the uterine wall thinner.

As noted, the device is safe and effective for adolescents who have reached menarche. It is often recommended as a first-line contraceptive for teens because it removes the 'user error' associated with daily pills. Clinical studies have shown that LARCs like Cupric Arsenite are highly effective in reducing unintended teen pregnancies.

This medication is not for use in postmenopausal women. In older premenopausal women (over age 45), the device can be used until menopause is confirmed. Healthcare providers must be cautious during insertion in older women, as the cervix may be more stenotic (narrowed).

No specific adjustments are required. The local nature of the device means that decreased kidney function does not lead to an accumulation of the drug in the system to a degree that would cause toxicity.

Aside from the absolute contraindication of Wilson's Disease, patients with chronic liver disease (such as cirrhosis) can generally use Cupric Arsenite safely, as it does not require hepatic metabolism. However, if liver disease has led to coagulopathy (blood clotting problems), the risk of heavy menstrual bleeding must be considered.

> Important: Special populations, particularly those who are postpartum or breastfeeding, require individualized medical assessment to determine the optimal timing for insertion.

Cupric Arsenite acts as a local foreign body within the uterine cavity. The primary molecular mechanism involves the continuous release of cupric ions (Cu2+). These ions are toxic to spermatozoa; they inhibit essential sperm enzymes, interfere with sperm motility, and prevent the sperm from undergoing the acrosomal reaction. The 'Arsenite' component, in trace amounts, may contribute to the localized cytotoxic environment, further ensuring that sperm cannot reach or fertilize an oocyte. Additionally, the device triggers a localized inflammatory response, increasing prostaglandin and white blood cell counts in the uterine fluid, which prevents a fertilized egg from implanting in the endometrium.

The onset of contraceptive effect is immediate upon insertion. Unlike hormonal methods, there is no 'lead-in' period required if the device is inserted during the first 7 days of the menstrual cycle. The duration of effect is constant as long as the device is in place, with a steady-state release of ions maintained for up to 10 years. There is no evidence of the body developing a 'tolerance' to the contraceptive effects of copper ions.

| Parameter | Value |

|---|---|

| Bioavailability | <0.1% (Systemic) |

| Protein Binding | N/A (Local ion action) |

| Half-life | N/A (Continuous release) |

| Tmax | N/A (Local onset <1 hour) |

| Metabolism | None (Inorganic ions) |

| Excretion | Menstrual flow / Cervical mucus |

• Molecular Formula: CuHAsO3
• Molecular Weight: 187.47 g/mol
• Solubility: Poorly soluble in water; slowly dissociates in the acidic/enzymatic environment of the uterine fluid.
• Structure: An inorganic salt consisting of copper (II) and the acid arsenite anion.

Cupric Arsenite is classified as a Copper-containing Intrauterine Device [EPC]. It is part of the broader category of Long-Acting Reversible Contraceptives (LARC). Related medications include the Copper T 380A (ParaGard), though Cupric Arsenite represents a specific salt formulation designed for controlled ion release.